Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kezar Life Sciences (KZR) Shares Outstanding (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed Shares Outstanding for 5 consecutive years, with $7.3 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding changed 0.38% to $7.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.3 million through Dec 2025, changed 0.38% year-over-year, with the annual reading at $7.3 million for FY2025, 0.38% changed from the prior year.
  • Shares Outstanding hit $7.3 million in Q4 2025 for Kezar Life Sciences, roughly flat from $7.3 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $68.4 million in Q3 2022 to a low of $5.6 million in Q4 2021.
  • Historically, Shares Outstanding has averaged $22.0 million across 5 years, with a median of $7.3 million in 2024.
  • Biggest five-year swings in Shares Outstanding: skyrocketed 41.95% in 2022 and later crashed 89.39% in 2023.
  • Year by year, Shares Outstanding stood at $5.6 million in 2021, then rose by 21.74% to $6.8 million in 2022, then grew by 6.26% to $7.3 million in 2023, then grew by 0.35% to $7.3 million in 2024, then rose by 0.38% to $7.3 million in 2025.
  • Business Quant data shows Shares Outstanding for KZR at $7.3 million in Q4 2025, $7.3 million in Q3 2025, and $7.3 million in Q2 2025.